Since c-Myc plays an important role in the transition from androgen-dependent prostate cancer to the androgen-refractory phenotype, we asked the question whether 5-Lox regulates c-Myc signaling and the viability of prostate cancer cells when they become resistant to enzalutamide therapy. Here, MYC is linked to Familial prostate cancer.